Foghorn Therapeutics Inc. Share Price
NASDAQ: FHTX | Micro CapFoghorn Therapeutics Inc. Stock Performance
Foghorn Therapeutics Inc. Share Price Today
As of 9 October 2026, Foghorn Therapeutics Inc.'s share price is $2.00. The stock opened at $2.00, compared to its previous close of $2.09. During today's trading session, Foghorn Therapeutics Inc.'s share price traded between $1.89 and $2.02, with an average price of $1.96. Over the past 52 weeks, the stock has recorded a high of $7.53 and a low of $1.80. In terms of performance, Foghorn Therapeutics Inc.'s share price has declined by 57.89% over the last six months and is down 54.65% on a year-on-year basis.
Foghorn Therapeutics Inc. Share Price Chart
Foghorn Therapeutics Inc. Quarterly Profit & Loss
All figures in USD
Foghorn Therapeutics Inc. Annual Profit & Loss
All figures in USD
About Foghorn Therapeutics Inc.
Foghorn Therapeutics Inc is a clinical stage, precision therapeutics biotechnology company focused on pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression through selectively targeting the chromatin regulatory system. Its proprietary platform is designed to provide an integrated, mechanistic understanding of interactions within the chromatin regulatory system, supporting the identification and validation of potential therapeutic targets. The company's flagship program is FHD-909.
Foghorn Therapeutics Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $1.98 | $2.00 | -44.12% |
Sep 2026 | $5.63 | $3.57 | -42.42% |
Aug 2026 | $4.56 | $6.20 | +36.41% |
Jul 2026 | $4.76 | $4.54 | -6.86% |
Jun 2026 | $4.31 | $4.88 | +13.89% |
May 2026 | $4.68 | $4.29 | -9.79% |
Apr 2026 | $4.97 | $4.75 | -0.63% |
Mar 2026 | $5.54 | $4.78 | -15.85% |
Feb 2026 | $5.91 | $5.68 | -1.05% |
Jan 2026 | $5.32 | $5.74 | +7.09% |
Dec 2025 | $4.66 | $5.36 | +13.80% |
Nov 2025 | $4.28 | $4.71 | +6.80% |